Dong Feng-qin, Li Hong, Wu Fang, Yao Hang-ping
First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou 310003, China.
Zhonghua Yi Xue Za Zhi. 2008 Dec 30;88(48):3444-7.
To investigate the effects of overexpression of decorin (DCN), one of the small leucine-rich proteoglycans, on the expression of extracellular matrix molecules in glomerular mesangial and tubular cells.
Recombinant adenovirus vector containing DCN gene (Ad/DCN) was constructed, and recombinant adenovirus containing LacZ gene (Ad/LacZ) was used as control vector. Rat renal glomerular mesangial cells of the line RMC and tubular cells of the line HK-2 were cultured and divided into following groups: high glucose + Ad/DCN transfection (experimental), high glucose + Ad/LacZ transfection (vector control), high glucose + neutralizing antibody against transforming growth factor (TGF)-beta 1 (positive control), high glucose non-transfection (PBS control), and low glucose culture (normal control) groups. Western blotting was used to detect the protein expression of decorin, TGF-beta 1, collagen type IV, MMP-2, and MMP-9.
The DCN protein expression was low only in the low glucose group, and was up-regulated in other groups, especially in the Ad/DCN group, so as the expression of TGF-beta 1 and collagen type IV, while the ratio of TGF-beta 1 to decorin is increased in both RMC and HK-2 cells. The expression levels of MMP-2 and MMP-9 decreased in the high-glucose-cultured RMC cells and increased in the high-glucose-cultured HK-2 cells, however, adenovirus-mediated transfection of decorin gene reversed all of these changes, and had almost the same effects on reducing the protein expression of TGF-beta 1 collagen type IV, MMP-2, and MMP-9 as anti-TGF-beta 1 antibody.
The agents increasing the decorin expression in mesangial and tubular cells may help prevent the development and progression of diabetic nephropathy. Overexpression of decorin may be a useful tool for developing new therapeutic application for the treatment of diabetic nephropathy.
研究富含亮氨酸的小分子蛋白聚糖之一的核心蛋白聚糖(DCN)过表达对肾小球系膜细胞和肾小管细胞中细胞外基质分子表达的影响。
构建含DCN基因的重组腺病毒载体(Ad/DCN),并以含LacZ基因的重组腺病毒(Ad/LacZ)作为对照载体。培养大鼠肾小球系膜细胞系RMC和肾小管细胞系HK-2,并分为以下几组:高糖+Ad/DCN转染组(实验组)、高糖+Ad/LacZ转染组(载体对照组)、高糖+抗转化生长因子(TGF)-β1中和抗体组(阳性对照组)、高糖未转染组(PBS对照组)和低糖培养组(正常对照组)。采用蛋白质印迹法检测核心蛋白聚糖、TGF-β1、IV型胶原、基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)的蛋白表达。
仅低糖组中DCN蛋白表达较低,其他组中表达上调,尤其是Ad/DCN组,TGF-β1和IV型胶原的表达也上调,而RMC和HK-2细胞中TGF-β1与核心蛋白聚糖的比例均增加。高糖培养的RMC细胞中MMP-2和MMP-9的表达水平降低,而高糖培养的HK-2细胞中表达增加,然而,腺病毒介导的核心蛋白聚糖基因转染逆转了所有这些变化,并且在降低TGF-β1、IV型胶原、MMP-2和MMP-9的蛋白表达方面与抗TGF-β1抗体具有几乎相同的作用。
增加系膜细胞和肾小管细胞中核心蛋白聚糖表达的药物可能有助于预防糖尿病肾病的发生和发展。核心蛋白聚糖的过表达可能是开发糖尿病肾病新治疗应用的有用工具。